Arena Pharmaceuticals Inc(ARNA) Finding the best opportunities to buy and sell stocks daily.

Sector:

Healthcare

Description:

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. Its investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, a Phase IIb/III clinical trial for Crohn's disease, and a Phase IIb clinical trial for atopic dermatitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; and APD418 that is in Phase I clinical trial for acute heart failure. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Beacon Discovery; Boehringer Ingelheim International GmbH; and Eisai Co., Ltd. and Eisai Inc. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California.

Current Price

$61.57

RSI

40.035

Beta:

0.5193

March 31, 2021
45.6M
-106.5M

-98.767 %
-148.845 %
-38.330 %
-28.067 %

$-4,204,000
$806,431,000
$17,970,000
$21,337,000
$92,163,000
$38,326,000
-100.521 %
4387.652 %
-15.780 %
-76.849 %
140.471 %

$-404,734,000
$507,888,000
$-139,664,000
$-95,854,000
$-22,896,000
$-108,013,000
-179.690 %
463.650 %
-45.705 %
-318.650 %
78.803 %

News

Press Releases

Notable Dates

All stock recommendations and comments are all opinions. Investors should be cautious about any and all stock recommendations and should consider the source of any advice on stock selection. Various factors, including personal ownership, may influence or factor into a stock analysis or opinion. All investors are advised to conduct their own independent research into individual stocks before making a purchase decision. In addition, investors are advised that past stock performance is not indicative of future price action.